$2.68
0.02[0.75%]
At close: Apr 19
$2.68
0[0.00%]
After Hours: 6:05PM EDT
Vivos Therapeutics
(NASDAQ:VVOS)Vivos Therapeutics Stock (NASDAQ:VVOS), Earnings Estimates, EPS, and Revenue
Vivos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 28
EPS
$-3.050
Quarterly Revenue
$3.2M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$13.8M
Analyze the earnings history of Vivos Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06/06/2024 | PM | VVOS | Q1 | -$1.75 | — | — | — | $3.86M | — | — | — | Get Alert |
| 03/28/2024 | PM | VVOS | Q4 | -$5.00 | -$1.90 | -$3.05 | -60.53% | $3.95M | $3.41M | $3.25M | -4.75% | Get Alert |
| 11/14/2023 | PM | VVOS | Q3 | -$6.50 | — | -$1.75 | — | $4.25M | — | $3.30M | — | Get Alert |
| 08/16/2023 | PM | VVOS | Q2 | -$8.25 | -$3.50 | -$4.50 | -28.57% | $4.18M | $4.15M | $3.40M | -18.19% | Get Alert |
| 06/08/2023 | PM | VVOS | Q1 | -$6.50 | -$4.50 | -$5.00 | -11.11% | $3.46M | $4.01M | $3.86M | -3.82% | Get Alert |
| 03/30/2023 | PM | VVOS | Q4 | -$8.50 | -$5.50 | -$5.00 | 9.09% | $4.39M | $4.55M | $3.95M | -13.19% | Get Alert |
| 12/20/2022 | PM | VVOS | Q2 | -$4.75 | — | -$8.25 | — | $4.50M | $3.81M | $4.18M | 9.82% | Get Alert |
| 12/20/2022 | PM | VVOS | Q3 | -$6.50 | — | -$6.50 | — | $4.55M | $3.72M | $4.25M | 14.14% | Get Alert |
| 05/16/2022 | PM | VVOS | Q1 | -$4.75 | -$6.50 | -$6.50 | 0.00% | $3.45M | $4.44M | $3.46M | -22.07% | Get Alert |
| 03/31/2022 | PM | VVOS | Q4 | -$12.00 | — | -$8.50 | — | $3.30M | — | $4.39M | — | Get Alert |
| 11/15/2021 | PM | VVOS | Q3 | -$4.25 | -$4.50 | -$6.50 | -44.44% | $3.29M | $4.50M | $4.55M | 1.02% | Get Alert |
| 08/12/2021 | PM | VVOS | Q2 | — | -$4.50 | -$4.75 | -5.56% | — | $3.60M | $4.50M | 24.92% | Get Alert |
| 05/17/2021 | PM | VVOS | Q1 | -$5.75 | — | -$4.75 | — | $3.20M | — | $3.45M | — | Get Alert |
| 03/25/2021 | PM | VVOS | Q4 | — | -$4.00 | -$12.00 | -200.00% | $3.10M | $3.21M | $3.30M | 2.80% | Get Alert |
FAQ
When is Vivos Therapeutics (NASDAQ:VVOS) reporting earnings?
Vivos Therapeutics (VVOS) is scheduled to report earnings on June 6, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
What were the latest earnings per share (EPS) for Vivos Therapeutics (NASDAQ:VVOS)?
The Actual EPS was $-3.05, which missed the estimate of $-1.90.
What were Vivos Therapeutics’s (NASDAQ:VVOS) revenues?
The Actual Revenue was $3.2M, which missed the estimate of $3.4M.
Browse earnings estimates, EPS, and revenue on all stocks.